FIELD: medicine.;SUBSTANCE: invention represents a diagnostic technique for polycystic ovarian syndrome (PCOS) in adolescents aged from 14 through 17 years by measuring urine 2-OHE1/16α-ONE1 ratio, differing by measuring the oestrogen metabolites 2-hydroxyestrone and 16α-hydroxyestrone in urine in vitro, deriving their ratio and comparing the calculated values to the determined normal values specific for healthy girls of the same age; PCOS is diagnosed if the value is 0.71±0.03.;EFFECT: more accurate non-invasive diagnosis using enzyme immunoassay.;4 ex
展开▼
机译：发明领域：本发明代表一种通过测量尿液2-OHE1 /16α-ONE1比值来检测14至17岁青少年多囊卵巢综合征（PCOS）的诊断技术，其不同之处在于通过测量雌激素代谢物2-羟基雌酮和16α体外尿液中的-羟基雌酮，求出它们的比例，并将计算值与确定的相同年龄健康女孩的正常值进行比较;如果该值是0.71±0.03，则诊断为PCOS。效果：使用酶免疫法进行更准确的无创诊断; 4 ex
展开▼
